Li Y - Search Results

1

[Management of Dermatologic Toxicities Related to Immune Checkpoint Inhibitors].

Si X, He C, Zhang L, Liu X, Li Y, Wang H, Guo X, Zhou J, Duan L, Zhang L. Si X, et al. Among authors: li y. Zhongguo Fei Ai Za Zhi. 2019 Oct 20;22(10):639-644. doi: 10.3779/j.issn.1009-3419.2019.10.06. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31650946 Free PMC article. Review. Chinese.

2

[Calpain I inhibition prevents pacing-induced structural remodeling for atrial fibrillation in canine].

Li WM, Xue HJ, Li Y, Zhang L, Gong YT, Sheng L, Chu S. Li WM, et al. Among authors: li y. Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Feb;35(2):132-6. Zhonghua Xin Xue Guan Bing Za Zhi. 2007. PMID: 17445406 Chinese.

3

[Effect of calpain 1 on structural remodeling and contractile dysfunction in atrial fibrillation: experiment with dogs].

Xue HJ, Li WM, Li Y, Gong YT, Sheng L, Zhang L, Chu S. Xue HJ, et al. Among authors: li y, li wm. Zhonghua Yi Xue Za Zhi. 2007 Aug 28;87(32):2285-8. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18001554 Chinese.

4

Calpain I inhibition prevents atrial structural remodeling in a canine model with atrial fibrillation.

Xue HJ, Li WM, Li Y, Gong YT, Yang BF, Jin CL, Sheng L, Chu S, Zhang L, Shan HB, Liu J. Xue HJ, et al. Among authors: li y, li wm. Chin Med J (Engl). 2008 Jan 5;121(1):32-7. Chin Med J (Engl). 2008. PMID: 18208663

5

[Influence of oxidative stress on atrial myocardium pathohistological and ultrastructural changes in atrial fibrillation: experiment with dogs].

Li WM, Sheng L, Li Y, Yang BF, Gong YT, Xue HJ, Yu JB, Zhang L, Shan HB, Liu J. Li WM, et al. Among authors: li y. Zhonghua Yi Xue Za Zhi. 2008 Apr 8;88(14):985-9. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18756973 Chinese.

6

Incidences of aortic and mitral valve strands in patients with migraine with aura.

Zhai YN, Li Y, Wei LQ, Zhang MQ, Lu HQ, Zhang L. Zhai YN, et al. Among authors: li y. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Apr;37(2):147-51. doi: 10.3881/j.issn.1000-503X.2015.02.003. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015. PMID: 25936701

7

[Diagnosis and Treatment Recommendation and Exploration for Critical and Refractory Adverse Effects Related to Immunocheckpoint Inhibitors].

Wang H, Song P, Si X, Guo X, Li Y, Zhou J, Duan L, Zhang L, Wang M, Zhang L. Wang H, et al. Among authors: li y. Zhongguo Fei Ai Za Zhi. 2019 Oct 20;22(10):605-614. doi: 10.3779/j.issn.1009-3419.2019.10.01. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31650941 Free PMC article. Review. Chinese.

8

[The Use of Glucocorticoid in the Management of Adverse Effects Related to Immunocheckpoint Inhibitors].

Wang H, Zhou J, Guo X, Li Y, Duan L, Si X, Zhang L. Wang H, et al. Among authors: li y. Zhongguo Fei Ai Za Zhi. 2019 Oct 20;22(10):615-620. doi: 10.3779/j.issn.1009-3419.2019.10.02. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31650942 Free PMC article. Review. Chinese.

9

[Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor].

Wang H, Guo X, Zhou J, Duan L, Si X, Zhang L, Li Y, Liu X, Wang M, Shi J, Zhang L. Wang H, et al. Among authors: li y. Zhongguo Fei Ai Za Zhi. 2019 Oct 20;22(10):621-626. doi: 10.3779/j.issn.1009-3419.2019.10.03. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31650943 Free PMC article. Review. Chinese.

10

[Clinical Diagnosis and Treatment Recommendations for Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor].

Guo X, Wang H, Zhou J, Duan L, Li Y, Si X, Zhang L, Fang L, Zhang L. Guo X, et al. Among authors: li y. Zhongguo Fei Ai Za Zhi. 2019 Oct 20;22(10):627-632. doi: 10.3779/j.issn.1009-3419.2019.10.04. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31650944 Free PMC article. Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240,746 results

Search Page

Filters